Skip to content

Effects of the Test Product for Skin

Effects of the Test Product for Skin - Effects of the Test Product for Skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026573
Enrollment
40
Registered
2017-03-17
Start date
2017-03-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A(healthy adults)

Interventions

Oral intake of the test product (4 capsules in a day
8 weeks) Oral intake of the placebo product (4 capsules in a day

Sponsors

TES Holdings Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: [1]Females aged 30-59 years. [2]Individuals who are healthy and have no chronic physical disease including skin disease. [3]Individuals who are concerning on dry skin. [4]Individuals whose written informed consent has been obtained. [5]Individuals who can have an examination in a designated day. [6]Individuals judged appropriate for the study by the principal.

Exclusion criteria

Exclusion criteria: [1]Individuals using medical products. [2]Individuals who developed asthma in the past 3 months. [3]Individuals who used or applied a drug for treatment of disease in the past 1 month. [4]Individuals with strange skin conditions at measurement points. [5]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. [6]Individuals who contract or have a history of serious gastrointestinal disease. [7]Individuals with serious anemia. [8]Individuals who are sensitive to test product or other foods, and medical products. [9]Individuals who are or are possibly pregnant, or are lactating. [10]Individuals who have an addiction to alcohol or a mental illness. [11]Individuals who are a smoker. [12]Individuals whose bowel habit is irregular. [13]Individuals with possible changes of life style, such as working a night shift or conducting a long-term travel, during the test period. [14]Individuals with probable seasonal allergy, such as pollinosis, during the test period. [15]Individuals who cannot avoid daylight exposure during the test period. [16]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period. [17]Individuals who have a habit to use drug claiming to improve skin condition in the past 3 months. [18]Individuals who use cosmetics having a strong moisturizing effect or improvingg effect for wrinkle. [19]Individuals who had been conducted an operation on the test spot in the past 6months. [20]Individuals who participated in other clinical studies in the past 3 months. [21]Individuals who and whose family work in a company developing or manufacturing functional foods. [22]Individuals judged inappropriate for the study by the principal.

Design outcomes

Primary

MeasureTime frame
[1]Transepidermal water loss, skin moisture content, skin viscoelasticity (Week 0, Week 8)

Secondary

MeasureTime frame
*Secondary outcomes [1]Observation for skin condition by a specialist (Week 0, Week 8) [2]Questionnaire of physical feeling (Week 0, Week 4, Week 8) *Other indexes [1]Diagnosis by doctors (Week 0, Week 8) [2]Subject's diary(From the first day of ingestion of a test material to the last day of the test)

Countries

Japan

Contacts

Public ContactRyoma Shimizu

TES Holdings Co., Ltd Administrative Department of Clinical Trials

r.shimizu@tes-h.co.jp03-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026